The expansion project has increased the site’s capacity by around 30,000ft² and enabled the installation of additional refrigerated and deep-frozen storage
Catalent has completed an expansion project of its clinical supply facility in Shanghai. (Credit: Myriam Zilles on Unsplash)
US-based pharma company Catalent has announced the completion of the expansion project of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
Under the project, the site has increased by about 30,000ft², which has enabled the installation of additional deep-frozen (between minus 70 and minus 90 degrees Celsius) and refrigerated (between 2 and 8 degrees Celsius) storage.
Additionally, Catalent announced the expansion of secondary packaging capabilities.
The firm will organise two client events on December 1 and December 6 to showcase the site’s facilities and conduct seminars on clinical supply management and new GMP regulations.
Catalent APAC Operations general manager Tracey Clare said: “China is the fastest growing clinical trials market in the Asia-Pacific region, and Catalent continues to invest and expand its facilities and services to offer reliable, flexible, and integrated support to customers.
“These additional capabilities increase the site’s ability to support clinical trials for advanced therapeutics, which often require specialised storage and handling capabilities.”
One of Catalent’s two clinical supply facilities in Shanghai is located in Waigaoqiao; the other is in Tangzhen, which is outside the FTZ.
Through Catalent’s wide network, they provide sponsors with efficient supply solutions for studies being conducted in China, the Asia-Pacific area, and internationally.
These include primary and secondary packaging, storage, and global distribution, clinical returns and destruction, comparator sourcing, FastChain demand-led supply, primary and secondary packaging, storage, and global distribution, said the company.
In September this year, Catalent announced an investment of $2.2m to expand its clinical supply facility in Singapore.
Under the investment, the firm said that it will install 35 new freezers for ultra-low temperature (ULT) storage, expanding the site’s footprint by over 20% to 31,000ft².